Today: 18 May 2026
Browse Category

BIT:UCG 25 September 2025 - 27 September 2025

Crypto’s Wild 48 Hours: Bitcoin Rebounds, DeFi Breakthroughs, NFT Surprises & Regulation Shake-Ups (Sept 26–27, 2025)

Crypto’s Wild 48 Hours: Bitcoin Rebounds, DeFi Breakthroughs, NFT Surprises & Regulation Shake-Ups (Sept 26–27, 2025)

Bitcoin dropped to around $109,000 amid $1.1 billion in liquidations before rebounding above $110,000 on Friday. Ethereum rose 3.8% to reclaim $4,000 after U.S. inflation data met expectations. Tether is seeking to raise $20 billion at a $500 billion valuation, with SoftBank and ARK Invest reportedly in talks. Nine major European banks announced plans for a euro-backed stablecoin to rival dollar tokens.
Shutdown Jitters, ETF Tsunami & Crypto Power Plays – Top Crypto News (Sept 24–25, 2025)

Shutdown Jitters, ETF Tsunami & Crypto Power Plays – Top Crypto News (Sept 24–25, 2025)

U.S. regulators fast-tracked crypto ETF approvals, with launches expected in early October and Grayscale debuting a Crypto 5 index ETF. Bitcoin and Ether fell mid-week as U.S. shutdown fears grew, with Ether dropping below $4,000. Nine European banks plan a euro stablecoin by 2026. Australia moved to license crypto platforms, while Hong Kong warned against unauthorized stablecoins.
25 September 2025

Latest articles

Quince Therapeutics Stock Faces Nasdaq Pressure After Fresh QNCX Filing

Quince Therapeutics Stock Faces Nasdaq Pressure After Fresh QNCX Filing

18 May 2026
Quince Therapeutics was last quoted at $1.15 before Monday’s Nasdaq open after Nantahala Capital Management disclosed 7.52% beneficial ownership. The company’s latest filing reported no current product candidates and raised substantial doubt about its ability to continue as a going concern. Quince is seeking shareholder approval for another reverse stock split at its June 11 meeting. The company remains out of compliance with Nasdaq’s $50 million market value rule.
Macy’s Gains Pre-Market as Berkshire Buys In — What’s Ahead for Traders

Macy’s Gains Pre-Market as Berkshire Buys In — What’s Ahead for Traders

18 May 2026
Macy’s shares rose in premarket trading after Berkshire Hathaway disclosed a new stake of 3.04 million shares, valued at about $55 million as of March 31. The stock closed Friday at $18.41 and last traded at $18.99 premarket with 128,170 shares exchanged. Macy’s will report first-quarter results on June 3. Tariffs, fuel costs, and weak discretionary spending remain risks for the retailer.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

18 May 2026
ImmunityBio said Monday five U.S. patents protect its Anktiva-plus-BCG bladder cancer treatment through at least 2035, following an exclusive U.S. supply deal with Japan BCG Laboratory. The company plans to seek FDA approval for the Tokyo-172 BCG strain, which is not yet approved in the U.S. ImmunityBio shares last traded at $7.97 before the Nasdaq open.
Why Virax Biolabs Stock Is Jumping Before the Bell Today

Why Virax Biolabs Stock Is Jumping Before the Bell Today

18 May 2026
Virax Biolabs shares jumped in pre-market trading Monday, indicated at $0.3458 after closing Friday at $0.1535. The move followed a sponsored TV segment featuring CEO James Foster and a new SEC filing showing Armistice Capital holds 4.99% of shares. ViraxImmune, the company’s main test, remains in development and is not approved for diagnostic use. No new company press release appeared over the weekend.

Popular

Micron Faces Key Monday After Volatile Week

Micron Faces Key Monday After Volatile Week

17 May 2026
Micron Technology shares closed at $724.66 on Friday, down 6.6% after a record-setting week, but remain up nearly 154% for the year. The drop followed a broader market selloff, with the S&P 500 down 1.2% and the Nasdaq off 1.5% as Treasury yields rose. Micron recently began sampling 256GB DDR5 server memory modules to partners. Samsung faces a possible strike May 21, potentially affecting memory chip supply.
Go toTop